BASILICA Procedure Prior to Valve-in-Valve TAVR in a Supra-Annular TAV Prosthesis.

BASILICA procedure laceration left main coronary artery transcatheter aortic valve replacement

Journal

JACC. Case reports
ISSN: 2666-0849
Titre abrégé: JACC Case Rep
Pays: Netherlands
ID NLM: 101757292

Informations de publication

Date de publication:
05 Apr 2023
Historique:
received: 11 09 2022
revised: 13 01 2023
accepted: 19 01 2023
medline: 20 4 2023
pubmed: 20 4 2023
entrez: 20 04 2023
Statut: epublish

Résumé

An 80-year-old man with a supra-annular transcatheter aortic valve (TAV) prosthesis presented with severe transvalvular aortic regurgitation 18 months after the TAV replacement procedure. The authors report the first ever valve-in-valve procedure using BASILICA (bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction) in such a supra-annular TAV prosthesis. Minimal paravalvular leakage, normal coronary artery flow, and easy coronary access were seen postimplantation. (

Identifiants

pubmed: 37077443
doi: 10.1016/j.jaccas.2023.101777
pii: S2666-0849(23)00052-9
pmc: PMC10106999
doi:

Types de publication

Case Reports

Langues

eng

Pagination

101777

Informations de copyright

© 2023 The Authors.

Déclaration de conflit d'intérêts

Dr Damlin has received speaker compensation from Edwards Lifesciences. Drs Settergren, Meduri, Rück, and Linder serve as proctors for Boston Scientific. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Références

EuroIntervention. 2022 Aug 05;18(5):e428-e429
pubmed: 35587184
Circ Cardiovasc Interv. 2021 May;14(5):e010238
pubmed: 34003670
JACC Cardiovasc Interv. 2022 Sep 26;15(18):1777-1793
pubmed: 36137681
Front Cardiovasc Med. 2022 Sep 14;9:902564
pubmed: 36187005
JACC Cardiovasc Interv. 2019 Jul 8;12(13):1240-1252
pubmed: 31202947
JACC Cardiovasc Interv. 2022 Aug 22;15(16):1678-1680
pubmed: 35981843
JACC Cardiovasc Interv. 2020 Mar 23;13(6):787-789
pubmed: 32192701
JACC Cardiovasc Interv. 2021 Mar 8;14(5):578-580
pubmed: 33358650

Auteurs

Anna Damlin (A)

Department of Clinical Physiology, Karolinska University Hospital, Stockholm, Sweden.
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
Unit of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

Christopher Meduri (C)

Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.

Aristomenis Manouras (A)

Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
Unit of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

Dinos Verouhis (D)

Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
Unit of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

Rickard Linder (R)

Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
Unit of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

Andreas Rück (A)

Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
Unit of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

Magnus Settergren (M)

Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
Unit of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

Classifications MeSH